» Articles » PMID: 34327714

A Literature Review and Best Practice Advice for Second and Third Trimester Risk Stratification, Monitoring, and Management of Pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation Of...

Citing Articles

Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia.

Ponthier L, El Hamel C, Coste Mazeau P, Martinez S, Wehbe S, Froget R BMC Pregnancy Childbirth. 2025; 25(1):1.

PMID: 39748304 PMC: 11697507. DOI: 10.1186/s12884-024-07102-w.


[Elevated blood pressure and hypertension : Focus of the 2024 ESC guidelines on risk reduction].

Schmieder R, Schunkert H Herz. 2024; 50(1):17-24.

PMID: 39589443 DOI: 10.1007/s00059-024-05285-8.


Posterior reversible encephalopathy syndrome (PRES) on the second postpartum day: learning experience from a case report and literature review.

Vuong A, Pham X, Nguyen P Int J Emerg Med. 2024; 17(1):118.

PMID: 39251910 PMC: 11386115. DOI: 10.1186/s12245-024-00707-0.


Exploration of the molecular characteristics and potential clinical significance of shared immune-related genes between preterm preeclampsia and term preeclampsia.

Huang Z, Sun L, Gao Y, Shi M, Zhang P, Ding Y BMC Pregnancy Childbirth. 2024; 24(1):543.

PMID: 39148025 PMC: 11328443. DOI: 10.1186/s12884-024-06526-8.


DEVELOPING A BEDSIDE TEST FOR PREECLAMPSIA: OVERCOMING SISYPHUS.

Thadhani R Trans Am Clin Climatol Assoc. 2024; 134:66-74.

PMID: 39135599 PMC: 11316904.


References
1.
Wright D, Poon L, Rolnik D, Syngelaki A, Delgado J, Vojtassakova D . Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017; 217(6):685.e1-685.e5. DOI: 10.1016/j.ajog.2017.08.110. View

2.
Bellamy L, Casas J, Hingorani A, Williams D . Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335(7627):974. PMC: 2072042. DOI: 10.1136/bmj.39335.385301.BE. View

3.
Nahum Sacks K, Friger M, Shoham-Vardi I, Sergienko R, Spiegel E, Landau D . Long-term neuropsychiatric morbidity in children exposed prenatally to preeclampsia. Early Hum Dev. 2019; 130:96-100. DOI: 10.1016/j.earlhumdev.2019.01.016. View

4.
Duhig K, Myers J, Seed P, Sparkes J, Lowe J, Hunter R . Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019; 393(10183):1807-1818. PMC: 6497988. DOI: 10.1016/S0140-6736(18)33212-4. View

5.
Chappell L, Brocklehurst P, Green M, Hunter R, Hardy P, Juszczak E . Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019; 394(10204):1181-1190. PMC: 6892281. DOI: 10.1016/S0140-6736(19)31963-4. View